Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD

Kidney International

Volumn 57, Issue 6, 2000, Pages 2546-2556

  Rippe, Bengt ^a,b   Levin, Lars ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Dialysate; Fluid and solute transport; Membrane permeability; Three pore model of peritoneal transport

Indexed keywords

ICODEXTRIN; OSMOTIC AGENT;

ARTICLE; COMPUTER SIMULATION; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; FLUID TRANSPORT; MEMBRANE PERMEABILITY; MODEL; MOLECULAR SIZE; OSMOLALITY; PRIORITY JOURNAL; ULTRAFILTRATION;

EID: 0034076951     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00114.x     Document Type: Article

References (31)

1. 1. RIPPE B, STELIN G: Simulations of peritoneal solute transport during CAPD: Application of two-pore formalism. Kidney Int 35:1234-1244, 1989
2. 2. RIPPE B, STELIN G, HARALDSSON B: Computer simulations of peritoneal fluid transport in CAPD. Kidney Int 40:315-325, 1991
3. 3. AGRE P, PRESTON BM, SMITH BL, JUNG JS, RAINA S, MOON C, GUGGINO WB, NIELSEN S: Aquaporin CHIP: The archetypal molecular water channel. Am J Physiol 265:F463-F476, 1993
4. 4. CARLSSON O, NIELSEN S, ZAKARIA ER, RIPPE B: In vivo inhibition of transcellular water channels (aquaporin-1 ) during acute peritoneal dialysis in rats. Am J Physiol 271:H2254-H2262, 1996
5. 5. PYLE WK, MONCRIEF JW, POPOVICH RP: Peritoneal Transport Evaluation in CAPD: CAPD Update, Continuous Ambulatory Peritoneal Dialysis. New York, Mason Publishing, 1981, pp 35-42
6. 6. VONESH EF, LYSAGHT MJ, MORAN J, FARRELL P: Kinetic modelling as a prescription aid in peritoneal dialysis. Blood Purif 9:246-270, 1991
7. 7. RIPPE B, ZAKARIA ER, CARLSSON O: Theoretical analysis of osmotic agents in peritoneal dialysis. What size is an ideal osmotic agent? Perit Dial Int 16(Suppl 1):S97-S103, 1996
8. 8. RIPPE B: A three-pore model of peritoneal transport. Perit Dial Int 13(Suppl 1):S35-S38, 1993
9. 9. VONESH EF, RIPPE B: Net fluid absorption under membrane transport models of peritoneal dialysis. Blood Purif 10:209-226, 1992
10. 10. DAVIES DS: Kinetics of icodextrin. Perit Dial Int 14(Suppl 2):S45-S50, 1994
11. 11. MISTRY CD, GOKAL R: Icodextrin in peritoneal dialysis: Early development and clinical use. Perit Dial Int 14(Suppl 2):S13-S21, 1994
12. 12. GOKAL R, MISTRY CD, PEERS E, MIDAS STUDY GROUP: A United Kingdom multicenter study of icodextrin in continuous ambulatory peritoneal dialysis. Perit Dial Int 14(Suppl 2):S22-S27, 1994
13. 13. MISTRY CD, GOKAL R, PEERS EM, MIDAS STUDY GROUP: A randomized multicenter clinical trial comparing isoosmolar icodextrin with hyperosmolar glucose solutions in CAPD. Kidney Int 46:496-503, 1994
14. 14. HO-DAC-PANNEKEET MM, SCHOUTEN N, LANGENDIJK MJ, HIRALALL JK, DE WAART DR, STRUIJK DG, KREDIET RT: Peritoneal transport characteristics with glucose polymer based dialysate. Kidney Int 50:979-986, 1996
15. 15. STELIN G, RIPPE B: A phenomenological interpretation of the variation in dialysate, with dwell time in CAPD. Kidney Int 38:465-472, 1990
16. 16. HARALDSSON B: Assessing the peritoneal dialysis capacities of individual patients. Kidney Int 47:1187-1198, 1995
17. 17. POSTHUMA N, WEE M, DONKER JM, OE L, VAN DORP W, PEERS E, VERBURGH H: Serum disaccharides and osmolality in CCPD patients using Icodextrin or glucose as daytime dwell. Perit Dial Int 17:602-607, 1997
18. 18. HEIMBÜRGER O, WANIEWSKI J, WERYNSKI A, TRANAEUS A, LINDTIOLM B: Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 38:495-505, 1990
19. 19. RIPPE B: How to measure ultrafiltration failure: 2.27% or 3.86% glucose? (editorial) Perit Dial Int 17:125-128, 1997
20. 20. RIPPE B, STELIN G, AHLMÉN J: Lymph flow from the peritoneal cavity in CAPD patients, in Frontiers in Peritoneal Dialysis, 4, edited by MAHER JF, WINCHESTER JF, New York, Field, Rich and Ass, Inc., 1986, pp 24-30
21. 21. HEIMBÜRGER O, WANIEWSKI J, WERYNSKI A, SUN PARK M, LINDHOLM B: Lymphatic absorption in CAPD patients with loss of ultrafiltration capacity. Blood Purif 13:327-339, 1995
22. 22. WANG T, HEIMBÜRGER O, CHENG HH, BERGSTRÖM J, LINDHOLM B: Peritoneal fluid and solute transport with different polyglucose formulations. Perit Dial Int 18:193-203, 1998
23. 23. POSTHUMA N, WEE PM, VERBURGH HA, OE PL, PEERS E, SAYERS J, DONKER AJM: Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance. Nephrol Dial Transplant 12:550-553, 1997
24. 24. WANG T, HEIMBÜRGER O, CHENG H, WANIEWSKI J, BFRGSTRÖM J, LINDHOLM B: Effects of dialysate fill, on peritoneal fluid and solute transport. Kidney Int 52:1068-1076, 1997
25. 25. DOUMA CE, HIRALALL JK, DE WAART DR, SIRUIJK DG, KREDIET RT: Icodexlrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells. Kidney Int 53:1014-1021, 1998
26. 26. WANIEWSKI J, HEIMBÜRGER O, WERYNSKI A, LINDHOLM B: Osmotic conductance of the peritoneum in CAPD patients with permanent loss of ultrafiltration capacity. Perit Dial Int 16:488-496, 1996
27. 27. TWARDOWSKI ZJ, NOLPH KD, KHANNA R: Peritoneal equilibration test. Perit Dial Bull 7:138-148, 1987
28. 28. DEDRICK RL, FLESSNER MF, COLLINGS JM, SCHULTZ, JS: Is the peritoneum a membrane? ASAIO J 5:1-8, 1982
29. 29. FLESSNER MF: Peritoneal transport physiology: Insights from basic research. J Am Soc Nephrol 2:122-135, 1991
30. 30. TWARDOWSKI ZJ, PROWANT BF, NOLPH KD, MARTINEZ AJ, LAMPTON LM: High, low frequency continuous ambulatory peritoneal dialysis. Kidney Int 23:64-70, 1983
31. 31. MASON EA, WENDI RP, BRESSLER EH: Similarity relations (dimensional analysis) for membrane transport. J Membr Sci 6:283-298, 1980